Several shortcomings of current Parkinson's disease (PD) models limit progress in identification of environmental contributions to disease pathogenesis. The conditionally immortalized cell line LUHMES promises to make human dopaminergic neuronal cultures more easily available, but these cells are difficult to culture for extended periods of time. We overcame this problem by culturing them in 3D with minor medium modifications. The 3D neuronal aggregates allowed penetration by small molecules and sufficient oxygen and nutrient supply for survival of the innermost cells. Using confocal microscopy, gene expression, and flow cytometry, we characterized the 3D model and observed a highly reproducible differentiation process. Visualization and qu...
Parkinson\u27s disease (PD) is a neurodegenerative disorder with no cure. The pathological hallmark ...
The induced pluripotent stem (iPS) cell field holds promise for in vitro disease modeling. However, ...
Background and purpose Few neuropharmacological model systems use human neurons. Moreover, availabl...
To date, most in vitro toxicity testing has focused on acute effects of compounds at high concentrat...
Human cell-based neural organoids are increasingly being used for investigations of neurotoxicity, a...
The pesticide rotenone, a neurotoxin that inhibits the mitochondrial complex I, and destabilizes mic...
<div><p>The pesticide rotenone, a neurotoxin that inhibits the mitochondrial complex I, and destabil...
Parkinson’s disease (PD) is the most common neurodegenerative movement disorder. The extensive loss ...
The use of cell-based models in neurotoxicology and for neurodegenerative diseases is driven by limi...
Oxidative stress is caused by an imbalance between the generation and detoxification of reactive oxy...
Abstract Parkinson’s disease (PD) does not manifest clinically until 80 % of striatal dopamine is re...
Parkinson’s disease (PD) is a progressive neurodegenerative disease characterised by the loss of mid...
Cellular models are instrumental in dissecting a complex pathological process into simpler molecular...
International audienceTo model α-Synuclein (αS) aggregation and neurodegeneration in Parkinson’s dis...
International audienceTo model α-Synuclein (αS) aggregation and neurodegeneration in Parkinson’s dis...
Parkinson\u27s disease (PD) is a neurodegenerative disorder with no cure. The pathological hallmark ...
The induced pluripotent stem (iPS) cell field holds promise for in vitro disease modeling. However, ...
Background and purpose Few neuropharmacological model systems use human neurons. Moreover, availabl...
To date, most in vitro toxicity testing has focused on acute effects of compounds at high concentrat...
Human cell-based neural organoids are increasingly being used for investigations of neurotoxicity, a...
The pesticide rotenone, a neurotoxin that inhibits the mitochondrial complex I, and destabilizes mic...
<div><p>The pesticide rotenone, a neurotoxin that inhibits the mitochondrial complex I, and destabil...
Parkinson’s disease (PD) is the most common neurodegenerative movement disorder. The extensive loss ...
The use of cell-based models in neurotoxicology and for neurodegenerative diseases is driven by limi...
Oxidative stress is caused by an imbalance between the generation and detoxification of reactive oxy...
Abstract Parkinson’s disease (PD) does not manifest clinically until 80 % of striatal dopamine is re...
Parkinson’s disease (PD) is a progressive neurodegenerative disease characterised by the loss of mid...
Cellular models are instrumental in dissecting a complex pathological process into simpler molecular...
International audienceTo model α-Synuclein (αS) aggregation and neurodegeneration in Parkinson’s dis...
International audienceTo model α-Synuclein (αS) aggregation and neurodegeneration in Parkinson’s dis...
Parkinson\u27s disease (PD) is a neurodegenerative disorder with no cure. The pathological hallmark ...
The induced pluripotent stem (iPS) cell field holds promise for in vitro disease modeling. However, ...
Background and purpose Few neuropharmacological model systems use human neurons. Moreover, availabl...